Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-12-000440

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Sep 30, 2012 82.33M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$5.96M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$87.88K
Sga Expense Q3 2012 · Sep 30, 2012 $2.58M
Sga Expense Q3 2012 · Sep 30, 2011 $14.8K
Sga Expense Q3 2012 · Sep 30, 2011 $49.02K
Rd Expense Q3 2012 · Sep 30, 2012 $1.3M
Net Income Q3 2012 · Sep 30, 2012 −$13.05M
Net Income Q3 2012 · Sep 30, 2011 −$152.18K
Current Liabilities Q3 2012 · Dec 31, 2011 $1.08M
Current Assets Q3 2012 · Dec 31, 2011 $8.68K
Total Assets Q3 2012 · Dec 31, 2011 $39.41K